Pre-Open Stock Movers

VPC Impact Acquisition (NASDAQ: VIH) 56% HIGHER; Crypto exchange Bakkt is said to be in advanced talks to go public through a merger with blank-check firm VPC Impact Acquisition (NASDAQ: VIH), according to a report from Bloomberg after the market close, citing people with knowledge of the matter.

Sarepta Therapeutics, Inc. (NASDAQ: SRPT) 52.7% LOWER; announced top-line results from Part 1 of Study SRP-9001-102 (Study 102), an ongoing, randomized, double-blind, placebo-controlled clinical trial to evaluate the safety, efficacy and tolerability of a single dose of SRP-9001 (rAAVrh74.MHCK7.micro-dystrophin) in 41 patients with Duchenne muscular dystrophy. SRP-9001 is an investigational gene transfer therapy intended to deliver its micro-dystrophin-encoding gene to muscle tissue for the targeted production of the micro-dystrophin protein. Study met the primary biological endpoint of micro-dystrophin protein expression at 12 weeks post-treatment, as measured by western blot, in SRP-9001-treated participants versus placebo; SRP-9001-treated participants showed an increase in NSAA total score compared to placebo at 48 weeks; however, the study did not achieve statistical significance on the primary functional endpoint of improvement in NSAA total score compared to placebo at 48 weeks post-treatment.

Globalstar, Inc. (NYSE: GSAT) 46.6% HIGHER; announced that business partner Nokia has entered into an agreement with Tideworks Technology, to deploy Globalstar’s Band 53 spectrum at the Port of Seattle, Terminal 5. This deployment marks the second collaboration between Globalstar and Nokia at a United States Port.

Chimerix (NASDAQ: CMRX) 30.7% HIGHER; announced that the Company has acquired Oncoceutics, Inc., a privately-held, clinical-stage biotechnology company developing imipridones, a novel class of compounds. Oncoceutics lead product candidate, ONC201, has been shown in clinical testing to selectively induce cell death in multiple cancer types. ONC201 is currently in a registrational clinical trial for recurrent H3 K27M-mutant glioma and a confirmatory response rate assessment is expected in 2021.

Merus N.V. (Nasdaq: MRUS) 26.7% HIGHER; announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation to Zenocutuzumab (Zeno) for the treatment of patients with metastatic solid tumors harboring NRG1 gene fusions (NRG1+ cancers) that have progressed on standard of care therapy.

Solid Biosciences Inc. (NASDAQ: SLDB) 26.3% LOWER; lower in sympathy with SRPT.

Neoleukin Therapeutics, Inc. (NASDAQ: NLTX) 23% LOWER; announced that on January 7, 2021, it received a clinical hold letter from the U.S. Food and Drug Administration (FDA) related to its Investigational New Drug (IND) Application to begin a Phase 1 clinical program of its immunotherapeutic candidate, NL-201.

MICT, Inc. (Nasdaq: MICT) 14.4% HIGHER; announces it has moved its core operations to Hong Kong to more efficiently serve its Asian clientele through its recently launched proprietary insurance platform as well as the anticipated stock trading platform expected to launch shortly.

WD-40 Co. (NASDAQ: WDFC) 13.9% HIGHER; reported Q1 EPS of $1.72, $0.69 better than the analyst estimate of $1.03. Revenue for the quarter came in at $124.6 million versus the consensus estimate of $106.85 million. WD-40 Co. sees FY2021 revenue of $435-470 million, versus the consensus of $426.24 million.

BIONANO GENOMICS, INC. (Nasdaq: BNGO) 11% LOWER; announced today that it plans to offer and sell, subject to market and other conditions, shares of its common stock in an underwritten public offering.

Plug Power Inc. (NASDAQ: PLUG) 8.9% HIGHER; adds to yesterday's 35% gains on South Korea deal

Cerecor Inc. (Nasdaq: CERC) 7.2% LOWER; intends to offer for sale shares of its common stock and, to a certain investor in lieu thereof, pre-funded warrants to purchase shares of common stock, in an underwritten public offering.

PriceSmart (NASDAQ: PSMT) 5.3% LOWER; reported Q1 EPS of $0.90, $0.22 better than the analyst estimate of $0.68. Revenue for the quarter came in at $877.4 million versus the consensus estimate of $837.37 million.

F5 Networks (NASDAQ: FFIV) 4% HIGHER; F5 and Volterra, the first universal edge-as-a-service platform, today announced a definitive agreement under which F5 will acquire all issued and outstanding shares of privately held Volterra for approximately $440 million in cash and approximately $60 million in deferred consideration and assumed unvested incentive compensation to founders and employees. With the addition of Volterras technology platform, F5 is creating an edge platform built for enterprises and service providers that will be security-first and app-driven with unlimited scale.

Uber (NYSE: UBER) 3.8% LOWER; Block of 38M Shares Said Offered Via Goldman Sachs at $53.90-$56.13/sh - Bloomberg (Earlier)

You May Also Be Interested In

• IBM tumbles on soft Q1 revenue; announces HashiCorp $6.4bn acquisition
• Standard BioTools (LAB) Announces Operational Restructuring Plan, Cuts 10% Staff
• Meta earnings, IBM to acquire HashiCorp, U.S. GDP ahead - what's moving markets